Company Overview: Chek

Industry News

10 Jan

Check-Cap Receives CE Mark Approval for C-Scan®

ISFIYA, Israel and BOSTON, Jan.10, 2018 /PRNewswire/ — Check-Cap Ltd. (the “Company” or “Check-Cap”) (CHEK) (NASDAQ: CHEKW), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for preparation-free, colorectal cancer screening, today announced it has received CE Mark approval for the C-Scan system. The C-Scan system offers an alternative...

Read more

5 Dec

Check-Cap Announces Advancement in GE Healthcare Manufacturing Collaboration

New Phase Supports C-Scan® Assembly, Testing & Distribution Initially for US Pilot Trial ISFIYA, Israel and BOSTON, Dec. 5, 2017 /PRNewswire/ — Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK, CHEKW), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for preparation-free, colorectal cancer screening, today announced it has...

Read more

20 Nov

Check-Cap Ltd. Announces $2.5 Million Registered Direct Offering

ISFIYA, Israel and BOSTON, Nov. 20, 2017 /PRNewswire/ — Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced that it has entered into definitive agreements with institutional investors for the purchase of 2,272,640 ordinary...

Read more

6 Nov

Check-Cap Reports Third Quarter 2017 Financial Results

ISFIYA, Israel and BOSTON, Nov. 6, 2017 /PRNewswire/ — Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK; CHEKW), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for preparation-free, colorectal cancer screening, today announced its financial results for the third quarter and nine months ended September 30, 2017. Continued...

Read more

24 Oct

Check-Cap Announces Acceptance of Late Breaking Clinical Performance Abstract at United European Gastroenterology Week 2017

ISFIYA, Israel and BOSTON, Oct. 24, 2017 /PRNewswire/ — Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK, CHEKW), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for preparation-free, colorectal cancer screening, today announced the acceptance of an abstract entitled “Clinical Performance of a Novel X-ray Based Imaging...

Read more

27 Sep

Check-Cap Announces Filing of CE Mark Registration for C-Scan®

Management Hosts Conference call at 9:00 a.m. EDT ISFIYA, Israel and BOSTON, Sept. 27, 2017 /PRNewswire/ –Check-Cap Ltd. (the “Company” or “Check-Cap”) (CHEK) (NASDAQ:CHEKW), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for preparation-free, colorectal cancer screening, today announced that it has filed for the CE Mark registration...

Read more

10 Aug

Check-Cap Reports Second Quarter 2017 Financial Results

ISFIYA, Israel and BOSTON, Aug. 10, 2017 /PRNewswire/ — Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK; CHEKW), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for preparation-free, colorectal cancer screening, today provided a corporate update and announced its financial results for the second quarter and six...

Read more

2 Jun

Check-Cap Ltd. Announces Closing of $2.69 Million Financing

ISFIYA, Israel and BOSTON, June 2, 2017 /PRNewswire/ — Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced the closing of the previously announced definitive agreement with a...

Read more

30 May

Check-Cap Ltd. Announces $2.69 Million Financing

ISFIYA, Israel and BOSTON, May 30, 2017 /PRNewswire/ — Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today announced that it has entered into a definitive agreement with a single...

Read more

Page 1 of 3123

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address